Year: 2024

Brian G. Morreale, M.Sc. (They/Them) Pre-Doctoral Candidate, Laboratory of Scott Abrams, PhD., Dept. of Immunology Roswell Park Comprehensive Cancer Center, Buffalo, USA
New Member Mini-Bios

New Member Mini-Bio Brian G. Morreale, M.Sc., Pre-Doctoral Candidate, Dept. of Immunology Roswell Park Comprehensive Cancer Center

April 30, 2024

Brian G. Morreale, M.Sc. (They/Them) Pre-Doctoral Candidate, Laboratory of Scott Abrams, PhD., Dept. of Immunology Roswell Park Comprehensive Cancer Center, Buffalo, USA @MorrealeBrian After graduating Daemen College in Amherst, NY, Mr. Morreale received his master’s degree in Cancer Sciences at Roswell Park Comprehensive Cancer Center, Buffalo, NY. There he was [READ MORE]

NAS election ICIS members
Member Highlights

Four ICIS Members Elected to the National Academy of Sciences

April 30, 2024

Congratulations to the following Lifetime ICIS members have been elected into the National Academy of Sciences in recognition of their distinguished and continuing achievements in original research.

Kaech, Susan M.; professor and director, NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, Calif.

O’Garra, Anne; professor and principal group leader, Immunoregulation and Infection Laboratory, The Francis Crick Institute (United Kingdom)

Trinchieri, Giorgio; chief, Laboratory of Integrative Cancer Immunology, distinguished investigator, and head, Cancer Immunology Section, Center for Cancer Research, National Institutes of Health, Bethesda, Md.

As well as long time ICIS member Mantovani, Alberto; emeritus professor of general pathology and vice rector for research, Humanitas University (Italy) [READ MORE]

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials

April 29, 2024

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory CancersClinicalTrials.gov ID NCT03388632Sponsor National Cancer Institute (NCI)Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party) Interleukin-34 Level in Periodontal DiseaseClinicalTrials.gov ID NCT05962567Sponsor Ain Shams UniversityInformation provided by Nada Zidan, Ain Shams University (Responsible Party) TNFalpha and Interleukin 2 [READ MORE]

Cytokines 2024 / KAI 2024 Collage
Annual Meeting

Have You Started Making Your Plans to Attend Cytokines 2024 / KAI 2024?

April 16, 2024

Have You Started Making Your Plan to Attend Cytokines 2024 / KAI 2024? Here’s Two More “Must Visit” Places in Seoul – and the latest list of symposia speakers confirmed by the Cytokine 2024 secretariat. [READ MORE]

Prof. Michael Gale Jr.
Members on the Move

Michael Gale, Jr. to become Director of the Institute on Infectious Diseases at University of Minnesota

April 16, 2024

Prof. Michael Gale, Jr. to head University of Minnesota’s Department of Microbiology and Immunology and become Director of the Institute on Infectious Diseases [READ MORE]

2023 ICIS-REGENERON AWARD WINNER – EDWARD CHUONG
YI Award Winners - Where are they now?

2023 ICIS-Regeneron Award Winner – Edward Chuong, Assistant Professor at the BioFrontiers Institute, at the University of Colorado Boulder

April 16, 2024

EDWARD CHUONG, Assistant Professor at the BioFrontiers Institute, at the University of Colorado Boulder  My lab studies the interplay between transposons and immune evolution. We can think of transposons as a genetic infection that we can never get rid of. Although our cells have evolved defenses against them, transposons are [READ MORE]

Old Pals (l to r): Phil Hansbro, Paul Hertzog, Luke O'Neill
Member Highlights

Member Highlight: Paul Hertzog, B.Sc (Honours), Ph.D., The University of Melbourne

April 16, 2024

There have been many great (Cytokines) meetings for different reasons. But the standout for me was Hawaii 2022. It was the first face-to-face meeting post COVID lockdown era and Melbourne had one of the longest at 265 days!!! So this was the first time we had seen our international family in over 3 years! The excitement was palpable. It brought home all the values of our Science and this Society. [READ MORE]

Ruby Dawson in Athens, Greece
Member Highlights

Member Highlight: Ruby Dawson, Postdoctoral Researcher, South Australian Immunogenomics Cancer Institute (SAiGENCI)

April 16, 2024

My research investigates the function of innate immune receptors in gastric cancer and gastric inflammation.

Being on the ICIS council as a junior member for the past few years has been invaluable for my career. It’s provided insight into how international societies work, how conferences are organised and given me experience in activities outside of pure research.

After COVID travel restrictions, it’s been great to meet collaborators face to face, some for the first time. The 2023 meeting in Athens was great. There were great talks, good food and fun networking sessions! The music from Luke O’Neill’s band was a highlight. [READ MORE]